Ascentry Appoints Ludovic d’Apréa as new Chief Executive Officer
Today, Ascentry announced the appointment of Ludovic d’Apréa as its new Chief Executive Officer (CEO)
Ludovic d’Apréa succeeds Cyril Verhille and will lead the company through its next phase of growth, innovation, and strategic development. With extensive experience across the healthcare IT, MedTech, and life sciences sectors, he brings a proven track record of leadership, business development, and value creation in international markets.
As CEO, Ludovic d’Apréa will be responsible for driving the company’s overall strategy, accelerating commercial growth, strengthening relationships with customers and partners, and advancing Ascentry’s mission to deliver innovative solutions that improve outcomes for healthcare providers and patients.
After 15 years at the head of Ascentry where he had the pleasure of growing the company to what it is today, Cyril Verhille felt the need to take-on a different role within the company by leading Ascentry’s Advisory Board. « I am delighted to welcome Ludovic as the new CEO of Ascentry, and have no doubt that he will lead the company to the next level with strategic and human intelligence. »
The Board expressed its confidence that under Ludovic’s leadership, Ascentry is well positioned to capitalize on new opportunities and further strengthen its position in the market.
“I am deeply honored to have been entrusted with this responsibility at such an exciting time, and I thank Cyril Verhille for his trust and steadfast support throughout this transition. His leadership, commitment, and guidance have been invaluable, and I am grateful for the opportunity to build upon the strong foundations he has helped create.” said Ludovic d’Apréa.